Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin® and Synulox® in healthy dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 26, Issue 3, 2003, Pages 165-171

  Vree, Tom B ^a   Dammers, E ^b   Van Duuren, E ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DADA Consultancy   (Netherlands)

^c Regivet BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOASSAY; CALCULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOG; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; MALE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANIMALS; AREA UNDER CURVE; CLAVULANIC ACID; CROSS-OVER STUDIES; DOGS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; MALE; REFERENCE VALUES;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037498558     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2003.00476.x     Document Type: Article

References (29)

1. Adam, D., deVisser, I. & Koeppe, P. (1982) Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrobial Agents and Chemotherapy, 22, 353-357.
2. Allen, G.D., Coates, P.E. & Davies, B.E. (1988) On the absorption of clavulanic acid. Biopharmaceutics and Drug Disposition, 9, 127-136.
3. Bolton, G.C., Allen, G.D., Davies, B.E., Filer, C.W. & Jeffery, D.J. (1986) The disposition of clavulanic acid in man. Xenobiotica, 16, 853-863.
4. Carceles, C.M., Escudero, E., Vicente, M.S., Serrano, J.M. & Carli, S. (1995) Pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous and oral administration in goats. The Veterinary Quarterly, 17, 134-138.
5. Chulavatnatol, S. & Charles, B.G. (1994) Determination of close-dependent absorption of amoxycillin from urinary excretion data in healthy subjects. British Journal of Clinical Pharmacology, 38, 274-277.
6. Cooper, C.E., Slocombe, B. & White, A.R. (1990) Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxicillin against beta-lactamase producing Branhamella catharrhasis and Haemophilus influenzae. Journal of Antimicrobial Chemotherapy, 26, 371-380.
7. Dahlhoff, A., Koeppe, P. & von Kobyietzki, D. (1981) Untersuchungen zur Pharmakokinetik von Amoxicillin nach intravenöser, intramuskulärer und oraler Applikation. Arzneimittelforschung, 31, 1148-1157.
8. Elias Jones, A., Barnes, N.D., Tasker, T.C.G. & Horton, R. (1990) Pharmacokinetics of intravenous amoxycillin and potassium clavulanate in seriously ill children. Journal of Antimicrobial Chemotherapy, 25, 269-274.
9. Fraschini, F., Scaglione, F., Falchi, M., Dugnani, S., Mezzetti, M., Cicchetti F., Alfano, G. & Pintucci, G.P. (1990) Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. Journal of Chemotherapy, 2, 171-177.
10. Haginaka, J., Nakagawa, T., Hoshino, T., Yamaoka, K. & Uno, T. (1981) Pharmacokinetic studies of urinary excretion of clavulanic acid in man. Chemical and Pharmaceutical Bulletin, 29, 3342-3349.
11. Horber, F.F., Frey, F.J., Descoeurders, C., Murray, A.T. & Reubi, F.C. (1986) Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrobial Agents and Chemotherapy, 29, 614-619.
12. Neu, H.C. (1984) Beta-lactamases: a perspective on the contribution of these enzymes to bacterial resistance. Postgraduate Medicine, 76 Suppl, 7-21.
13. Neu, H.C. & Fu, K.P. (1984) Clavulanic acid, a novel inhibitor of β-lactamases. Antimicrobial Agents and Chemotherapy, 14, 650-655.
14. Nilsson-Ehle, I., Fellner, H., Hedström, S.A., Nilsson-Ehle, P. & Sjövall, J. (1985) Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers. Journal of Antimicrobial Chemotherapy, 16, 491-498.
15. Paintaud, G., Alván, G., Dahl, M.L., Sjövall, J. & Svensson, J.O. (1992) Nonlinearity of amoxicillin absorption kinetics in human. European Journal of Clinical Pharmacology, 43, 283-288.
16. Piotrovskij, V.K., Paintaud, G., Alván, G. & Trnovec, T. (1994) Modelling of the saturable time-constrained amoxicillin absorption in humans. Pharmaceutical Research, 11, 1346-1351.
17. Reed, M.D. (1998) The clinical pharmacology of amoxicillin and clavulanic acid. Pediatric Infection Journal, 17, 957-962.
18. Sinko, P.J. & Amidon, G.L. (1989) Characterization of the oral absorption of beta-lactam antibiotics. Competitive absorption and peptide carrier specificity. Journal of Pharmaceutical Sciences, 78, 723-726.
19. Sjövall, J., Alván, G. & Westerlund, D. (1985) Dose-dependent absorption of amoxycillin and bacampicillin. Clinical Pharmacology and Therapeutics, 38, 241-250.
20. Sjövall, J., Alván, G., Åkerlund, J.E., Svensson, J.O., Paintaud, G., Nord, C.E. & Angelin, B. (1992) Dose-dependent absorption of amoxicillin in patients with ileostomy. European Journal of Clinical Pharmacology, 43, 277-281.
21. Soback, S., Bor, A., Kurtz, B., Paz, R. & Ziv, G. (1987) Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves. Journal of Veterinary Pharmacology and Therapeutics, 10, 105-113.
22. Staniforth, D.H., Jackson, D., Horton, R. & Davies, B. (1984) Parenteral augmentin: pharmacokinetics. International Journal of Clinical Pharmacology Therapy and Toxicology, 22, 430-434.
23. Todd, P.A. & Benfield, P. (1990) Amoxicillin/clavulanic acid - an update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 39, 264-307.
24. Torres-Molina, F., Peris-Ribera, J.E., García-Carbonell, M.C., Aristorena, J.C., & Plá-Delfina, J.M. (1992) Nonlinearities in amoxycillin pharmacokinetics. II. Absorption studies in the rat. Biopharmaceutics and Drug Disposition, 13, 39-53.
25. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S. & Craig, W.A. (1998) Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases, 158, 831-847.
26. ten Voorde, G., Broeze, J., Hartman, E.G. & van Gogh, H. (1990) The influence of the injection site on the bioavailability of ampicillin and amoxycillin in beagles. The Veterinary Quarterly, 12, 73-79.
27. Vree, T.B., Baars, A.M. & van der Kleijn, E. (1978) Rapid determination of amoxycillin and ampicillin in body fluids of man by means of HPLC. Journal of Chromatography, 146, 103-112.
28. Vree, T.B., Dammers, E. & Exler, P.S. (2003) Identical pattern of highly variable absorption of clavulanic acid from four different oral formulations of amoxicillin-clavulanic acid in healthy subjects. Journal of Antimicrobial Chemotherapy, 51, 373-378.
29. Watson, A.D.J., Emslie, D.R., Martin, I.C.A. & Egerton, J.R. (1986) Effect of ingesta on systemic availability of penicillins administered orally to dogs. Journal of Veterinary Pharmacology and Therapeutics, 9, 140-149.